Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
GLO1 cg26053840 Methylation Associates with Kidney Injury and Inflammatory Markers in Hospitalized Older Adults.
Life (Basel, Switzerland)·2026
Related Experiment Video
Updated: May 26, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Inflammation, chronic obstructive pulmonary disease and aging.
Mauro Provinciali1, Maurizio Cardelli, Francesca Marchegiani
1Advanced Technology Center for Aging Research, Scientific Technological Area, INRCA-IRCCS, Ancona, Italy. m.provinciali@inrca.it
Current Opinion in Pulmonary Medicine
|January 3, 2012
Summary
Aging of the immune system, or immunosenescence, may predispose individuals to chronic obstructive pulmonary disease (COPD). Shared molecular mechanisms between COPD and aging suggest a link between immune system aging and COPD development.
More Related Videos
Area of Science:
- Immunology
- Gerontology
- Pulmonology
Background:
- Chronic obstructive pulmonary disease (COPD) involves persistent inflammation from environmental factors like cigarette smoke.
- The immune system's dysregulation is key in COPD onset and progression, but its determinants are not fully understood.
- Aging is characterized by chronic systemic inflammation, linked to various age-related diseases.
Purpose of the Study:
- To investigate molecular mechanisms regulating inflammatory pathways in COPD and aging.
- To explore the role of cytokine polymorphisms, miRNA expression, and DNA methylation.
- To provide evidence that immune system aging (immunosenescence) may predispose individuals to COPD.
Main Methods:
- Examined molecular mechanisms of inflammation.
- Analyzed cytokine polymorphisms.
- Assessed miRNA expression and DNA methylation patterns in COPD and aging.
Main Results:
- COPD incidence rises with age.
- COPD pathogenesis involves chronic inflammation and immune cell regulation.
- Chronic systemic inflammation in aging correlates with many age-related diseases.
Conclusions:
- COPD and aging share immune system dysregulation leading to chronic inflammation.
- Similar molecular mechanisms and genetic signatures link COPD and aging.
- Immunosenescence is suggested as a contributing factor to COPD development.